{"transactions":[{"id":961185,"issuer":{"id":6935,"kind":"organization","name":"CITIUS ONCOLOGY, INC."},"owners":[{"id":70997,"kind":"person","name":"Smith Robert Joseph","position":1,"cik":"0002008764","reported_name":"Smith Robert Joseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-22T16:10:09.000Z","date":"2025-09-19","kind":"grant","planned":false,"acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units granted on September 19, 2025. The shares underlying the restricted stock units will vest in full on the third anniversary of the grant date, subject to the Reporting Person's Continuous Service to Citius Oncology, Inc. (the \"Company\") or a Related Entity (as defined in the award agreement) as of the applicable vesting date."}],"balance_after":300000,"source":{"system":"sec-edgar","filing":"0001213900-25-124532","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2008764/000121390025124532/ownership.xml","form_type":"4/A","original_submission_date":"2025-09-23"}},{"id":985269,"issuer":{"id":6935,"kind":"organization","name":"CITIUS ONCOLOGY, INC."},"owners":[{"id":70997,"kind":"person","name":"Smith Robert Joseph","position":1,"cik":"0002008764","reported_name":"Smith Robert Joseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-01T16:10:15.000Z","date":"2025-09-19","kind":"grant","planned":false,"acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock awards granted on September 19, 2025. The shares will vest in full on the third anniversary of the grant date, subject to the Reporting Person's Continuous Service to Citius Oncology, Inc. (the \"Company\") or a Related Entity (as defined in the award agreement) as of the applicable vesting date."}],"balance_after":300000,"source":{"system":"sec-edgar","filing":"0001213900-25-116676","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2008764/000121390025116676/ownership.xml","form_type":"4/A","original_submission_date":"2025-09-23"}},{"id":1033883,"issuer":{"id":6935,"kind":"organization","name":"CITIUS ONCOLOGY, INC."},"owners":[{"id":70997,"kind":"person","name":"Smith Robert Joseph","position":1,"cik":"0002008764","reported_name":"Smith Robert Joseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-23T16:10:24.000Z","date":"2025-09-19","kind":"grant","planned":false,"acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock awards granted on September 19, 2025. The shares will vest in three substantially equal installments on the first, second and third anniversaries of the grant date, subject to the Reporting Person's Continuous Service to Citius Oncology, Inc. (the \"Company\") or a Related Entity (as defined in the award agreement) as of the applicable vesting date."}],"balance_after":300000,"source":{"system":"sec-edgar","filing":"0001213900-25-090615","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2008764/000121390025090615/ownership.xml","form_type":"4"}},{"id":1331082,"issuer":{"id":6935,"kind":"organization","name":"CITIUS ONCOLOGY, INC."},"owners":[{"id":70997,"kind":"person","name":"Smith Robert Joseph","position":1,"cik":"0002008764","reported_name":"Smith Robert Joseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-12-16T16:08:33.000Z","date":"2024-12-12","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on December 12, 2024. The options will vest 100% on the one-year anniversary of the grant date, provided that the Optionee provides Continuous Service to the Company as of the vesting date."}],"balance_after":125000,"derivative":{"exercise_price":1.07,"expiration_date":"2034-12-12","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001213900-24-109301","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2008764/000121390024109301/ownership.xml","form_type":"4"}},{"id":1369288,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70997,"kind":"person","name":"Smith Robert Joseph","position":1,"cik":"0002008764","reported_name":"Smith Robert Joseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Purchase Common Stock)","published_at":"2024-11-12T17:00:29.000Z","date":"2024-11-07","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on November 7, 2024. The options will vest 100% on the one-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of the vesting date."}],"balance_after":125000,"derivative":{"exercise_price":0.38,"expiration_date":"2034-11-07","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001213900-24-096894","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2008764/000121390024096894/ownership.xml","form_type":"4"}},{"id":1572794,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70997,"kind":"person","name":"Smith Robert Joseph","position":1,"cik":"0002008764","reported_name":"Smith Robert Joseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Purchase Common Stock)","published_at":"2024-03-18T16:06:03.000Z","date":"2024-03-14","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on March 14, 2024, with a Vesting Commencement Date of March 12, 2024, the date of the Optionee's election to the Board of the Company. The options will vest 100% on the one-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of the vesting date."}],"balance_after":75000,"derivative":{"exercise_price":0.69,"expiration_date":"2034-03-12","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001213900-24-023487","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2008764/000121390024023487/ownership.xml","form_type":"4"}}]}